8:00 am Registration & Networking
8:40 am Chair’s Opening Remarks
8:45 am FDA Insight: Utilizing 3D Models to Drive Drug Development & Regulatory Acceptance
9:15 am Human-on-a-Chip Systems for Use in Therapeutic Index Determination & Systemic Toxicity in Pre-Clinical Drug Discovery Application
9:45 am The Development & Application of 3D Culture Techniques to Construct Models of Human Tissues
10:15 am Speed Networking & Morning Networking Break
11:30 am Human Blood–Brain Barrier On-a-Chip
12:00 pm Stem Cell Derived Organoids on PDMS-Free Modular Chips
12:30 pm Aracari Biosciences Case Study
12:45 pm Networking Lunch
Preclinical Validation & Strategy of 3D Model Systems
1:45 pm Diabetes on a Chip
Andreas Stahl
Professor, Dept. of Nutritional Sciences & Toxicology, UC Berkeley
2:15 pm Patient-Derived Scaffolds Uncover Breast Cancer Promoting Properties of the Microenvironment
Göran Landberg,
Professor, University of Gothenburg
2:45 pm Multiorgan Physiomimetic Models for the Studies of Autoimmune & Neurodegenerative Diseases
Martin Trapecar
Postdoctoral Associate, MIT
1:45 pm 3D Bioprinting of Functional Human Tissue & Disease Models for Preclinical Studies
MinJae Song,
Staff Scientist - 3D Bioprinting Core, National Institute of Health Sciences
2:15 pm Aspiration-Assisted Bioprinting
Ibrahim Ozbolat
Associate Professor, Penn State
2:45 pm Automated Electrical Stimulation & Optical Force Readout of 3D Bioprinted Human Muscle Tissues in Microplates
Hansjoerg Keller
Senior Principal Scientist, Novartis
3:15 pm Afternoon Networking
4:30 pm Roundtable Discussion
This is your opportunity to share your thoughts and address key challenges across the industry alongside 100+ preclinical experts.